Carcinogenesis Advance Access published online on April 9, 2007
Carcinogenesis, doi:10.1093/carcin/bgm077
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The functional genetic variant Arg324Gly of frizzled-related protein (FRZB) is associated with colorectal cancer risk
1 Helmholtz-University Group Molecular Epidemiology, German Cancer Research Center, Heidelberg, Germany
2 Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany
3 Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
4 Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany
* Corresponding author: Kalai Selvi Shanmugam, German Cancer Research Center (DKFZ), Division of Molecular Genetic Epidemiology, Im Neuenheimer Feld 580, 69120 Heidelberg, Germany. E-mail: k.shanmugam{at}dkfz.de, Tel.: +49-6221-421811, Fax: +49-6221-421810
The Wnt/ß-catenin pathway plays a central role in colorectal tumorigenesis. Frizzled-related protein (FRZB, also termed secreted frizzled-related protein 3, sFRP3) antagonizes the signaling of wingless (Wnt) ligands through the frizzled membrane-bound receptors, resulting in ß-catenin destabilization thereby suppressing the expression of target genes. Recently, the FRZB Gly324 variant has been shown to have an attenuated ability to antagonize Wnt signaling and to be associated with an increased osteoarthritis risk. Here, we investigated, for the first time, the role of Arg324Gly (970C>G) along with Arg200Trp (598C>T) on colorectal cancer (CRC) risk by analyzing 659 patients and 607 control individuals drawn from the German DACHS (Darmkrebs: Chancen der Verhütung durch Screening) study. While Arg200Trp showed no effect on CRC risk, we found homozygous carriers of Gly324 more frequent in cases than in controls, leading to a significantly increased risk for CRC (OR = 5.1, 95% CI = 1.74-14.71, P < 0.001). The association was stronger in rectal cancer (OR = 7.52, 95% CI = 2.40-23.25, P < 0.0001) than in colon cancer (OR = 3.66, 95% CI = 1.14-11.76, P < 0.05). Since modified Wnt signaling and down-regulation of frizzled-related proteins have been observed in many human cancers, this variant may also affect the susceptibility to other cancers.
Key Words: colorectal cancer secreted frizzled-related protein 3 polymorphism Wnt/ß-catenin genetic risk factor
Received January 29, 2007; revised March 23, 2007; accepted March 28, 2007.